The largest community of pharma leaders

Frazier Healthcare Partners Announces Four Promotions

SEATTLE–()–Frazier Healthcare Partners is pleased to announce four promotions: Kent Berkley and Ryan Lucero to Principal, and Jennifer Martin and Carol Eckert to Vice President.

“We are proud to recognize the achievements of Kent, Ryan, Jennifer and Carol with these well-deserved promotions,” said Ben Magnano, Frazier Managing Partner. “Each of these professionals has made a meaningful impact on the firm, working alongside our portfolio companies and serving our investors with dedication and integrity.”

The promotions of Kent and Ryan expand the Principal group on the Growth Buyout IP team to four, as they join Christina Miller Reszka and Phil Zaorski. Of the promotions, Ben Magnano said, “Both Kent and Ryan demonstrate leadership and innovation in developing investment opportunities for the firm and have been invaluable to the growth and success of Frazier. I have great confidence in the depth and scope of their abilities as senior members of our growing IP team.” Continued Ben, “Jennifer’s promotion to Vice President of Finance reflects years of exemplary work, strong leadership and dedication to the firm, and Carol’s to Vice President of Investor Relations, is recognition of her instrumental efforts leading fundraising and building a topnotch IR, marketing and communications organization at Frazier.”

Kent Berkley – Principal – Kent joined Frazier in 2016 as a Vice President and is on the IP team for several of Frazier’s portfolio companies including Matrix Medical Network, Parata and Caravel Autism Health. Before coming to Frazier, Kent spent four years with The Edgewater Funds where he focused on leveraged buyout and growth equity investments in the healthcare, industrial and business services industries. Prior to Edgewater, Kent was an Associate with CIVC Partners and worked for Dresner Partners and Lehman Brothers.

Ryan Lucero – Principal – Ryan joined Frazier in 2016 as a Vice President and serves on the boards of MedData, EPTAM and United Digestive and is on the IP team for several portfolio companies including PCI. Before joining Frazier, Ryan spent five years with Kohlberg & Company where he focused on leveraged buyout and growth equity investments. Previously, Ryan worked for JPMorgan Chase & Co. and was also a member of the investment team for the Troubled Asset Relief Program (TARP) of the U.S. Department of the Treasury in Washington, DC.

Jennifer Martin – Vice President of Finance – Jennifer joined Frazier in 2015 in the firm’s accounting, treasury and finance group. She has extensive experience in hedge and private equity fund activities, including multiple fund structures and standard control practices, and has advised numerous asset managers in the implementation of new financial accounting and disclosure requirements. Prior to joining Frazier, Jennifer was the CFO of Red Mountain Capital Partners, a hedge fund manager located in Los Angeles. She was also previously a manager with PricewaterhouseCoopers in the Asset Management audit practice.

Carol Eckert – Vice President of Investor Relations – Carol joined Frazier in 2016 as Director of Investor Relations, heading up IR, marketing and communications for the Growth Buyout team. She helped lead the latest fundraise, FHGB IX, which closed in April of 2018. Carol came to Frazier after several years in private accounting consulting. She began her career in public accounting at Deloitte in Seattle, and then as Director of Accounting at Immunex Corporation.

About Frazier Healthcare Partners:

Founded in 1991, Frazier Healthcare Partners is a leading provider of growth and venture capital to healthcare companies. With nearly $4.8 billion in total capital raised, Frazier has invested in more than 200 companies with investments ranging from company creation and venture capital to buyouts of profitable lower-middle market companies. The firm’s Growth Buyout team invests in healthcare and pharmaceutical services, medical products and related sectors. The Life Sciences team invests in therapeutics and related areas that are addressing unmet medical needs through innovation. Frazier has offices in Seattle, Wash., and Menlo Park, Calif., and invests broadly across the U.S., Canada and Europe.

For more information about Frazier Healthcare Partners, visit


Recent Articles